Executive Order 14081: Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy [1] in September 2022 marked a change in thinking about the U.S. bioeconomy. The order summarizes the situation perfectly: “The...
Ecosystem Development
U.S. Strategy for Innovation – “Out Innovate With Everyone”
The National Advisory Council on Innovation and Entrepreneurship (NACIE) recently issued ten strategic recommendations for strengthening US entrepreneurship. The report highlights three critical areas: growing our future industries, accessing startup funding, and...
Building the Future Bioeconomy
This month's article discusses the challenges and solutions for establishing a robust U.S. bioeconomy. The President's Executive Order on innovation in biotechnology and biomanufacturing calls for agencies to submit reports on furthering societal goals related to...
What are Some Possible Outcomes of the FDA Modernization Act of 2022?
The Impact of the FDA Modernization Act 2.0 Late in December 2022, President Biden signed H.R. 2617 (117th): Consolidated Appropriations Act into law. While boringly titled, this Act contained the FDA Modernization Act 2.0, proposed initially as S.5002. While this...